The Diagnostic profile and clinical course of patients with rheumatic diseases in the medical intensive care unit

被引:0
|
作者
Aydin, Kaniye [1 ]
Turk, Ipek [2 ]
机构
[1] Cukurova Univ, Fac Med, Dept Internal Med, Div Med Intens Care Unit, Adana, Turkiye
[2] Cukurova Univ, Fac Med, Dept Internal Med, Div Rheumatol, Adana, Turkiye
关键词
Flare-up; infection; intensive care unit; mortality; systemic lupus erythematosus; systemic rheumatic disease; platelet to lymphocyte ratio; CRITICALLY-ILL PATIENTS; CLASSIFICATION CRITERIA; RHEUMATOLOGIC DISEASES; AMERICAN-COLLEGE; REVISED CRITERIA; OUTCOMES; DEFINITIONS; MANAGEMENT; SEPSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Immunosuppressive and immunomodulatory treatments developed in recent years as a result of a better understanding of the pathophysiology of systemic rheumatic diseases (SRDs) improve the prognosis. Despite medical advances, individuals with SRDs at any stage may require intensive care and have a high mortality rate. The aim of this study was to investigate the demographic and clinical characteristics of patients with rheumatic diseases admitted to the intensive care unit (ICU), and the factors associated with the risk of mortality.Materials and methods: This was a retrospective, cross-sectional study that included patients with rheumatic diseases in the medical ICU. Factors of ICU 28-day mortality were identified by multiple-variable logistic analysis.Results: A total of 127 patients with SRDs admitted to the medical ICU were enrolled. Systemic lupus erythematosus (SLE) (32.3%) was the most common diagnosis of SRDs in patients admitted to the ICU. The reasons for admission to the ICU were combined infection and primary SRD flare-up (35.4%), primary SRD flare-up (22%), SRD-unrelated reasons (22%), infection (17.3%), drug side effects (3.9%), and SRD-related complications (0.8%). The most common organ dysfunctions before (49.6%) and during (77.2%) admission to ICU were in the respiratory system. The 28-day mortality was 78 (61.4%). While the maximum procalcitonin, serum lactate, and blood urea nitrogen (BUN) levels were higher in the nonsurvivor group, the platelet and serum albumin levels were statistically significantly lower than those in the survivor group (p < 0.05). Acute respiratory failure (ARF), the presence of septic shock, the need for invasive mechanical ventilation (IMV), BUN level, and low platelet-lymphocyte ratio (PLR) were significant in the final multiple-variable model.Conclusion: Significant predictors of mortality in patients with rheumatic diseases may include ARF, septic shock, the need for IMV, and high BUN and low PLR levels.
引用
收藏
页码:1084 / 1093
页数:11
相关论文
共 50 条
  • [1] Outcome of Patients With Systemic Rheumatic Diseases Admitted to a Medical Intensive Care Unit
    Cavallasca, Javier A.
    del Rosario Maliandi, Maria
    Sarquis, Sergio
    Betina Nishishinya, Maria
    Schvartz, Alejandra
    Capdevila, Abelardo
    Nasswetter, Gustavo G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (08) : 400 - 402
  • [2] Prognosis of patients with rheumatic diseases admitted to intensive care
    Beil, M.
    Sviri, S.
    de la Guardia, V.
    Stav, I.
    Ben-Chetrit, E.
    van Heerden, R. V.
    ANAESTHESIA AND INTENSIVE CARE, 2017, 45 (01) : 67 - 72
  • [3] Epidemiology and outcome of patients with rheumatic diseases in the intensive care unit
    Keysser, Gernot
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (10): : 925 - 931
  • [4] Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know
    Mustafa, Mohanned
    Chelliah, Easwaradhas Gladston
    Hughes, Michael
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (07) : 1163 - 1168
  • [5] Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit
    Wang, Meiying
    Su, Shengyuan
    Lv, Jiyang
    Zhou, Gengmin
    Wang, Qingwen
    Guo, Chengshan
    EGYPTIAN RHEUMATOLOGIST, 2018, 40 (01) : 63 - 66
  • [6] Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit
    Schneeweiss-Gleixner, Mathias
    Hillebrand, Caroline
    Jaksits, Stephanie
    Fries, Jonathan
    Zauner, Michael
    Heinz, Gottfried
    Sengoelge, Guerkan
    Staudinger, Thomas
    Zauner, Christian
    Aletaha, Daniel
    Machold, Klaus P.
    Schellongowski, Peter
    Becede, Manuel
    RMD OPEN, 2023, 9 (04):
  • [7] Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran
    Arjmand, Mojgan
    Shahriarirad, Reza
    Shenavandeh, Saeedeh
    Fallahi, Mohammad Javad
    CLINICAL RHEUMATOLOGY, 2022, 41 (12) : 3859 - 3868
  • [8] Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit
    Mickaël Moreels
    Christian Mélot
    Marc Leeman
    Intensive Care Medicine, 2005, 31 : 591 - 593
  • [9] Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit
    Moreels, M
    Mélot, C
    Leeman, M
    INTENSIVE CARE MEDICINE, 2005, 31 (04) : 591 - 593
  • [10] Rheumatic patients in the intensive care unit
    Lehmann, P.
    Bruennler, T.
    Salzberger, B.
    Fleck, M.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2012, 107 (05) : 391 - 396